Anti-HLA-A Antibody (R2N34)

Catalog No.

RHM00102

Species reactivity

Human

Host species

Rabbit

Isotype

IgG

Clonality

Monoclonal

Tested applications

FCM: 1:20-1:100, IF: 1:50-1:200, IHC: 1:100-1:200, WB: 1:1000-1:2000

Target

HLAA, Human leukocyte antigen A, HLA class I histocompatibility antigen, A alpha chain, HLA-A

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P04439, P01889, P01891, P01892, P13746, P16188, P30450

Applications

FCM, IF, IHC, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.05% BSA, 50% Glycerol, 0.05% Sodium azide.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 4 ℃ for frequent use. Store at -20 ℃ for twelve months from the date of receipt.

Clone ID

R2N34

Bispecific antibody targeting shared indel-derived neoantigen of APC., PMID:40443649

TEIPP-vaccination in checkpoint-resistant non-small cell lung cancer: a first-in-human phase I/II dose-escalation study., PMID:40436854

Risk Factors of Acute Rejection: Impact on Graft Outcomes in a Cohort of Kidney Transplant Recipients., PMID:40429368

Biological and Clinical Relevance of Genetic Alterations in Peripheral T-cell Lymphomas., PMID:40416001

Targeting intracellular LMP2 with costimulatory signal-armed antibody-like TCR T cells., PMID:40401520

Repeated HLA-DRB1 and HLA-DQB1 Mismatches Without Preformed DSA Affect Graft Survival, Rejection and DSA Development: A Multicenter Analysis., PMID:40387242

HLA-C*01:02 and -C*04:03 May Confer Susceptibility to Treponema pallidum Infection in the Chinese Han Population., PMID:40361234

Conversion Surgery Performed Following Durvalumab Combined With Gemcitabine and Cisplatin in Cholangiocarcinoma: A Case Report., PMID:40294984

Evaluating the Antigen and Eplet Accuracy of DQA1 Imputations With the HaploSFHI Two-Field HLA Typing Inference Tool., PMID:40269614

Targeted theranostic nanomedicine using targeted CT-imageable particles that release tebentafusp., PMID:40244495

Relevance of Human Leukocyte Antigen Class C Donor-Specific Antibodies in Kidney Transplant., PMID:40223381

Characterizing HLA-A2-restricted CD8+ T-cell epitopes and immune responses to Omicron variants in SARS-CoV-2-inactivated vaccine recipients., PMID:40170856

Persistent neonatal alloimmune thrombocytopenia caused by triple anti-HLA-A11, -B3901, and -Cw7 antibodies., PMID:40159572

Pivotal epitopes for islet antigen-specific CD8+ T cell detection improve classification of suspected type 1 diabetes with the HLA-A*0201 allele., PMID:40133500

Haploidentical Hematopoietic Cell Transplantation in Dyskeratosis Congenita with Myelodysplastic Syndrome/Acute Myeloid Leukemia., PMID:40061174

Development of a T cell engaging bispecific antibody targeting long non-coding RNA PVT1., PMID:40035876

HLA Association With AQP4-IgG-Positive Neuromyelitis Optica Spectrum Disorder in the Korean Population., PMID:40020215

Occlusion of TCR binding to HLA-A*11:01 by a non-pathogenic human alloantibody., PMID:40009199

Advancing risk stratification in kidney transplantation: integrating HLA-derived T-cell epitope and B-cell epitope matching algorithms for enhanced predictive accuracy of HLA compatibility., PMID:40007544

Vaccine Development T-cell (MHC-I) Epitopes Identification Against the Indian HCV Genotype: An Approach Based on Immunoinformatic., PMID:39994132

Immunotherapy targeting a leader sequence cathepsin G-derived peptide., PMID:39939820

Predicted Indirectly Recognizable T-cell Epitope (PIRCHE) Load Correlates With Rejection Events After Simultaneous Pancreas-Kidney Transplantation., PMID:39936136

Genetic associations with measles PRNT and IgG antibody response to MMR vaccination in 6- and 15-month-old children., PMID:39914254

T cell immune evasion by SARS-CoV-2 JN.1 escapees targeting two cytotoxic T cell epitope hotspots., PMID:39875585

Characterization of a 3S PRAME VLD-Specific T Cell Receptor and Its Use in Investigational Medicinal Products for TCR-T Therapy of Patients with Myeloid Malignancies., PMID:39858024

In Situ Detection of Individual Classic MHC-I Gene Products in Cancer., PMID:39804685

Sensitization on Hemodialysis After Renal Graft Failure: HLA Incompatibility Still Matters., PMID:39757057

Existence and significance of anti-HLA-C autoantibodies to primary and persistent platelet transfusion refractoriness in patients with hematologic disorders: a retrospective study from a single centre., PMID:39731480

HLA Class I and II Alleles in Anti-Acetylcholine Receptor Antibodies Positive and Double-Seronegative Myasthenia Gravis Patients of Romanian Descent., PMID:39728756

Impact of repeat human leukocyte antigen mismatches on kidney graft survival: A contemporary Collaborative Transplant Study analysis., PMID:39716692

Enhancing HBV-specific T cell responses through a combination of epigenetic modulation and immune checkpoint inhibition., PMID:39700467

Cytomegalovirus-Specific T-Cell-Receptor-like Antibodies Target In Vivo-Infected Human Leukocytes Inducing Natural Killer Cell-Mediated Antibody-Dependent Cellular Cytotoxicity., PMID:39684614

Entry into the lytic cycle exposes EBV-infected cells to NK cell killing via upregulation of the MICB ligand for NKG2D and activation of the CD56bright and NKG2A+KIR+CD56dim subsets., PMID:39676862

Targeting peptide antigens using a multiallelic MHC I-binding system., PMID:39672954

Staggered immunization with mRNA vaccines encoding SARS-CoV-2 polymerase or spike antigens broadens the T cell epitope repertoire., PMID:39589869

Safety and Tolerability of Letetresgene Autoleucel (GSK3377794): Pilot Studies in Patients with Advanced Non-Small Cell Lung Cancer., PMID:39576208

MAGE-A4 pMHC-targeted CAR-T cells exploiting TCR machinery exhibit significantly improved in vivo function while retaining antigen specificity., PMID:39572159

HLA-B*15 Is Associated With SARS-CoV-2 Infection in a Brazilian Population., PMID:39530176

Basiliximab vs. No Induction Therapy in Kidney Transplant Recipients with a Low Immunological Risk Profile Receiving Tacrolimus/Mycophenolate/Steroids Maintenance Immunosuppression., PMID:39458101

T Cell Peptide Prediction, Immune Response, and Host-Pathogen Relationship in Vaccinated and Recovered from Mild COVID-19 Subjects., PMID:39456150

A new strategy for systematically classifying HLA alleles into serological specificities: Update and refinement., PMID:39435845

Sustained HIV remission after allogeneic hematopoietic stem cell transplantation with wild-type CCR5 donor cells., PMID:39222660

IL-2-armored peptide-major histocompatibility class I bispecific antibodies redirect antiviral effector memory CD8+ T cells to induce potent anti-cancer cytotoxic activity with limited cytokine release., PMID:39205483

Effects of Teprotumumab and Role of Human Leukocyte Antigens Markers in Patients With Thyroid Eye Disease., PMID:39187158

Next-generation sequencing reveals additional HLA class I and class II alleles associated with type 1 diabetes and age at onset., PMID:39185409

The Consequences of HLA Screening in the Prevention of Graft-Versus-Host Disease in Living Donor Liver Transplantation., PMID:39177044

High resolution HLA genotyping with third generation sequencing technology-A multicentre study., PMID:39132735

TCR-like bispecific antibodies toward eliminating infected hepatocytes in HBV mouse models., PMID:39109538

Isolation of pure primary term human cytotrophoblasts and their differentiation into syncytiotrophoblast-like cells as an ex vivo model of the human placenta., PMID:39089887

Hu8F4-CAR T cells with mutated Fc spacer segment improve target specificity and mediate anti-leukemia activity in vivo., PMID:39033444

Document Download

Anti-HLA-A Antibody (R2N34).pdf